Healthcare

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 23 Feb 2026  |  Global  |  Technology Research

    Consumer Wellness Trends and Technologies for the Next 5 Years

    Megatrend Shifts, Technological Advancements, Patent Signals, and Consumer Behavior Insights

    This report offers a forward-looking analysis of the consumer wellness landscape through 2030 by examining how rapid technological progress, evolving consumer expectations, and cross-industry convergence are reshaping wellness into a data-driven and highly personalized ecosystem. It revolves around the shift from reactive care toward proactive, pre...

    $4,950.00
  2. 20 Feb 2026  |  Global  |  Technology Research

    Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

    $950.00
  3. 04 Feb 2026  |  Global  |  Technology Research

    Growth Opportunities in AI-Based Simulation Modeling in Healthcare

    Multimodal AI, AR/VR Integration, and Generative AI to Drive Transformational Growth

    Traditional training environments face patient safety risks, resource constraints, and limited exposure to rare event scenarios. Additionally, physical simulations are costly, limiting accessibility (especially in resource-constrained settings). Current simulation models lack personalization, resulting in operational complexity for hospitals due to...

    $4,950.00
  4. 23 Jan 2026  |  Global  |  Technology Research

    Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...

    $950.00
  5. 20 Jan 2026  |  Global  |  Market Research

    Global Healthcare IT Investment Growth Opportunities, 2026

    Administrative AI and Provider Operations Garnered Investment Focus, Driving Transformational Growth

    The global healthcare IT and digital health investment landscape is entering a new maturity curve, shaped by AI-driven operational transformation, consolidation, and platform-centric models. Funding is rebounding selectively, with capital concentrating in enterprise infrastructure, provider operations, and hybrid virtual care ecosystems. Administra...

    $2,450.00
  6. 19 Jan 2026  |  Global  |  Technology Research

    Next-Generation Terahertz (THz) Imaging and Sensing for Healthcare and Security Applications

    Unlocking Safe, Smart, and Spectrally Aware Imaging for Healthcare and Security Markets

    This study provides an in-depth examination of recent advancements in next-generation terahertz (THz) imaging and sensing technologies and their increasingly transformative impact across healthcare diagnostics and security-related applications. It focuses on how emerging THz systems, enabled by significant progress in quantum cascade lasers (QCLs),...

    $4,950.00
  7. 13 Jan 2026  |  Global  |  Strategic Imperatives

    Top 10 Strategic Imperatives in the Healthcare Cloud Market, 2026

    The Top Transformations Impacting Future Growth Potential

    The healthcare cloud market is undergoing rapid transformation, driven by strategic imperatives that will redefine industry dynamics in 2026. Frost & Sullivan’s analysis identifies 10 critical shifts shaping this evolution, anchored in technological innovation, regulatory compliance, and operational resilience. Cloud adoption is no longer limited t...

    $2,450.00
  8. 30 Dec 2025  |  Global  |  Market Research

    Voice of Customer—Healthcare Cloud User Survey, Q3 2025

    AI Acceleration, Cloud-Native Modernization, and Edge Adoption Power Healthcare’s Digital Transformation

    This study examines how healthcare organizations are advancing their cloud strategies amid rising demand for AI, increased financial pressures, and growing operational complexity. Findings show that the cloud has become the core foundation of digital transformation, with adoption shifting from basic migration toward modernization, automation, and A...

    $4,950.00
  9. 19 Dec 2025  |  Global  |  Technology Research

    Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...

    $950.00
  10. 16 Dec 2025  |  Europe  |  Market Outlook

    Top 10 Growth Opportunities in the European Life Sciences Industry, 2026

    Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience

    Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

    $2,450.00